Summary
Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
Market Segment as follows:
By Type
Deflazacort
Prednisone
Others
By Application
Male
Female
By Company
PTC Therapeutics
Sarepta Therapeutics
Bristol-Myers Squibb
ITALFARMACO
BioMarin
Daiichi Sankyo
Solid Biosciences
Summit Therapeutics
FibroGen
NS Pharma
Pfizer
ReveraGen BioPharma
Wave Life
Genethon
Santhera Pharmaceuticals
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Interested in this report?
Get your sample now!
Table of Content
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Deflazacort
1.1.2.2 Prednisone
1.1.2.3 Others
1.1.3 Market by Application
1.1.3.1 Male
1.1.3.2 Female
1.2 Global and China Market Size
1.2.1 Global Overview
1.2.2 China Overview
2 Global and China Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 China
2.2.1 China Sales by Company
2.2.2 China Price by Company
3 Global and China Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 China
3.2.1 China Sales by Type
3.2.2 China Price by Type
4 Global and China Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 China
4.2.1 China Sales by Application
4.2.2 China Price by Application
5 China Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 PTC Therapeutics
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Sarepta Therapeutics
6.3 Bristol-Myers Squibb
6.4 ITALFARMACO
6.5 BioMarin
6.6 Daiichi Sankyo
6.7 Solid Biosciences
6.8 Summit Therapeutics
6.9 FibroGen
6.10 NS Pharma
6.11 Pfizer
6.12 ReveraGen BioPharma
6.13 Wave Life
6.14 Genethon
6.15 Santhera Pharmaceuticals
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion
Figure Deflazacort Market Size and CAGR 2013-2018 (Million USD)
Figure Deflazacort Market Size and CAGR 2013-2018 (Volume)
Figure Deflazacort Market Forecast and CAGR 2019-2025 (Million USD)
Figure Deflazacort Market Forecast and CAGR 2019-2025 (Volume)
Figure Prednisone Market Size and CAGR 2013-2018 (Million USD)
Figure Prednisone Market Size and CAGR 2013-2018 (Volume)
Figure Prednisone Market Forecast and CAGR 2019-2025 (Million USD)
Figure Prednisone Market Forecast and CAGR 2019-2025 (Volume)
Figure Others Market Size and CAGR 2013-2018 (Million USD)
Figure Others Market Size and CAGR 2013-2018 (Volume)
Figure Others Market Forecast and CAGR 2019-2025 (Million USD)
Figure Others Market Forecast and CAGR 2019-2025 (Volume)
Figure Male Market Size and CAGR 2013-2018 (Million USD)
Figure Male Market Size and CAGR 2013-2018 (Volume)
Figure Male Market Forecast and CAGR 2019-2025 (Million USD)
Figure Male Market Forecast and CAGR 2019-2025 (Volume)
Figure Female Market Size and CAGR 2013-2018 (Million USD)
Figure Female Market Size and CAGR 2013-2018 (Volume)
Figure Female Market Forecast and CAGR 2019-2025 (Million USD)
Figure Female Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Duchenne Muscular Dystrophy Market Size and CAGR 2013-2017 (Million USD)
Figure Global Duchenne Muscular Dystrophy Market Size and CAGR 2013-2017 (Volume)
Figure Global Duchenne Muscular Dystrophy Market Forecast and CAGR 2019-2025 (Million USD)
Figure Global Duchenne Muscular Dystrophy Market Forecast and CAGR 2019-2025 (Volume)
Figure China Duchenne Muscular Dystrophy Market Size and CAGR 2013-2017 (Million USD)
Figure China Duchenne Muscular Dystrophy Market Size and CAGR 2013-2017 (Volume)
Figure China Duchenne Muscular Dystrophy Market Forecast and CAGR 2019-2025 (Million USD)
Figure China Duchenne Muscular Dystrophy Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Duchenne Muscular Dystrophy SWOT List
Figure Duchenne Muscular Dystrophy Porter's Five Forces
